Accelerate Diagnostics Inc Asset Turnover Ratio (AXDX), as of fourth quarter 2024, current and historic results, rankings and more - CSIMarket
CSIMarket
 


Accelerate Diagnostics Inc   (NASDAQ: AXDX)
 

Accelerate Diagnostics Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Accelerate Diagnostics Inc asset turnover ratio, the ability of Accelerate Diagnostics Inc 's assets to generate revenue in the fourth quarter 2024, increased sequentially to 0.4 in the fourth quarter (Dec 31 2024), AXDX's balance sheet remain strong.

Within sector 11 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the fourth quarter 2024 compared to the preceding quarter from 1798 to 2513.

Asset Turnover Ratio Definition



AXDX Asset Turnover Ratio (Dec 31 2024)
IV. Quarter
(Sep 30 2024)
III. Quarter
(Jun 30 2024)
II. Quarter
(Mar 31 2024)
I. Quarter
(Dec 31 2023)
IV. Quarter
Y / Y Asset Change -13.1 % -17.25 % -54.04 % -37.52 % -48.14 %
Y / Y Revenue Change -6.97 % 157.99 % -4.39 % -3.17 % 1.82 %
Asset Turnover Ratio (TTM) 0.4 0.39 0.31 0.26 0.23
AXDX's Total Ranking # 2513 # 1798 # 1801 # 2527 # 2219
Seq. Asset Change -17.03 % 45.11 % -26.57 % -1.7 % -20.99 %
Seq. Revenue Change -1.4 % 6.73 % -1.73 % -10.04 % 173.44 %



Asset Turnover Ratio Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 12
Healthcare Sector # 360
Overall Market # 2513

Asset Turnover Ratio Statistics
High Average Low
0.38 0.1 0
(Sep 30 2024)   (Sep. 30, 2014)







Companies with similar Asset Turnover Ratio for the quarter ending Dec 31 2024, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Dec 31 2024 Assets at quarter ending Dec 31 2024
Nrc Health  1.13 $ 143.060  Millions$ 126.087  Millions
Neuraxis Inc   1.13 $ 2.686  Millions$ 2.370  Millions
Phibro Animal Health Corporation  1.13 $ 1,105.115  Millions$ 977.423  Millions
Reshape Lifesciences Inc  1.13 $ 7.057  Millions$ 6.258  Millions
Equillium Inc   1.12 $ 41.095  Millions$ 36.630  Millions
Pro dex Inc   1.12 $ 61.003  Millions$ 54.427  Millions
Universal Health Services Inc   1.11 $ 15,827.935  Millions$ 14,235.289  Millions
The Pennant Group Inc   1.11 $ 695.240  Millions$ 626.748  Millions
Amedisys Inc  1.11 $ 2,348.324  Millions$ 2,121.267  Millions
Inogen Inc   1.09 $ 335.705  Millions$ 306.719  Millions
Precipio inc   1.09 $ 18.532  Millions$ 16.972  Millions
Natera Inc   1.09 $ 1,696.911  Millions$ 1,559.219  Millions
Puma Biotechnology Inc   1.08 $ 230.468  Millions$ 213.301  Millions
Sanara Medtech Inc   1.08 $ 86.533  Millions$ 80.233  Millions
Precision Optics Corporation Inc   1.07 $ 18.683  Millions$ 17.483  Millions
Medpace Holdings Inc   1.07 $ 2,109.054  Millions$ 1,975.191  Millions
Inspire Medical Systems inc   1.06 $ 801.818  Millions$ 754.702  Millions
Adma Biologics Inc   1.06 $ 424.769  Millions$ 401.643  Millions
Organogenesis Holdings Inc   1.04 $ 482.043  Millions$ 461.457  Millions
Avadel Pharmaceuticals Plc  1.04 $ 168.840  Millions$ 161.977  Millions
Pacs Group Inc   1.03 $ 4,089.734  Millions$ 3,957.149  Millions
Vivos Therapeutics Inc   1.03 $ 15.019  Millions$ 14.569  Millions
Tactile Systems Technology Inc   1.03 $ 292.688  Millions$ 284.118  Millions
Lifeloc Technologies Inc   1.02 $ 8.538  Millions$ 8.352  Millions
Tela Bio Inc   1.01 $ 68.488  Millions$ 67.907  Millions
Sonoma Pharmaceuticals Inc   1.00 $ 13.973  Millions$ 13.942  Millions
Tandem Diabetes Care Inc   0.99 $ 939.574  Millions$ 950.984  Millions
Addus Homecare Corp  0.98 $ 1,154.021  Millions$ 1,174.022  Millions
Nuo Therapeutics Inc   0.98 $ 1.365  Millions$ 1.393  Millions
Acadia Pharmaceuticals Inc   0.97 $ 957.797  Millions$ 983.457  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.